Sona Nanotech Inc (TSE:SONA) has released an update.
Sona Nanotech Inc. has awarded 25,000 stock options to a consultant, with a vested interest accruing every six months and an exercise price of $0.30 per share. Simultaneously, the company is advancing its innovative Targeted Hyperthermia cancer therapy, which employs gold nanoparticles for effective tumor treatment and is moving towards regulatory approvals.
For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.
